Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cumberland PharmaceuticalsCPIX +2.55%34 Days Sales Outstanding is 7,608.38 as of Jun. 2026, which is 7652% above its 10-year median of 98.15. GuruFocus rates CPIX with a GF Score™ of 34/100 and a GF Value™ of $2.06 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 945 Drug Manufacturers companies, Cumberland Pharmaceuticals ranks worse than 89.42% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cumberland Pharmaceuticals Days Sales Outstanding Chart
CPIX vs BGM, ZYBT, TLPH: Days Sales Outstanding Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cumberland Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cumberland Pharmaceuticals Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cumberland Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Cumberland Pharmaceuticals's Days Sales Outstanding falls into.
Cumberland Pharmaceuticals Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 7,608.38 mean?
Cumberland Pharmaceuticals (CPIX) has a Days Sales Outstanding of 7,608.38 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Cumberland Pharmaceuticals and its competitors. This is 7652% above median its historical median of 98.15. Over the past decade, Cumberland Pharmaceuticals' Days Sales Outstanding has ranged from 69.74 to 152.63. According to the industry distribution chart, Cumberland Pharmaceuticals ranks #845 out of 945 companies in the Drug Manufacturers industry, placing it in the top 89.4%.
Is Cumberland Pharmaceuticals' Days Sales Outstanding too high?
Cumberland Pharmaceuticals' current Days Sales Outstanding of 7,608.38 is 7652% above median its 10-year median of 98.15. Over the past 10 years, this metric has ranged from a low of 69.74 to a high of 152.63. The Drug Manufacturers industry median Days Sales Outstanding is 71.76. Cumberland Pharmaceuticals' value of 7,608.38 is 10502.5% above this industry median. Based on the distribution chart, Cumberland Pharmaceuticals ranks #845 out of 945 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cumberland Pharmaceuticals has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cumberland Pharmaceuticals' Days Sales Outstanding compare to BGM and ZYBT?
According to the Drug Manufacturers industry distribution chart, Cumberland Pharmaceuticals ranks #845 out of 945 companies for Days Sales Outstanding. This places Cumberland Pharmaceuticals in the lower half of its industry. The industry median Days Sales Outstanding is 71.76. Cumberland Pharmaceuticals' value of 7,608.38 is 10502.5% above this benchmark. Historically, Cumberland Pharmaceuticals' own Days Sales Outstanding has ranged from 69.74 to 152.63 over the past decade. While the company's 10-year median is 98.15 vs. the industry median of 71.76, Cumberland Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.76, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cumberland Pharmaceuticals's current Days Sales Outstanding of 7,608.38 is 10502.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Cumberland Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cumberland Pharmaceuticals's current Days Sales Outstanding is 7,608.38, which is 7652% above median its own 10-year median of 98.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cumberland Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cumberland Pharmaceuticals (CPIX) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.06, compared to a current price of $7.65 — trading 271.4% above its estimated fair value. The current Days Sales Outstanding is 7,608.38, which is 7652% above median its 10-year median of 98.15 and 10502.5% above the Drug Manufacturers industry median of 71.76. Cumberland Pharmaceuticals' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Cumberland Pharmaceuticals (CPIX), the current Days Sales Outstanding is 7,608.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cumberland Pharmaceuticals (CPIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cumberland Pharmaceuticals stock appears to be overvalued.
The current stock price of $7.65 is trading 271.4% above its estimated GF Value™ of $2.06.
GuruFocus considers Cumberland Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for CPIX:
Days Sales Outstanding: 7,608.38 (7652% above median its 10-year median of 98.15)
GF Value™: $2.06 vs. price of $7.65 (271.4% above fair value)
Industry Position: 10502.5% above the Drug Manufacturers median (#845 of 945)
No single metric tells the full story. See the CPIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
34GF Score
Get the complete analysis for CPIX
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CPIX has been successfully added to your 
